Pfizer pledges to sell all of its products at cost to poor countries
Boehringer, Takeda make it into global top 15 employer list
EMA weighs new safety guidance for Novartis’ gene therapy Zolgensma
Medtech approvals stagnate
*please scroll down for all the latest news*
